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CancerIn all eukaryotic cells, the endoplasmic reticulum (ER) and the mitochondria establish a tight interplay, which is
structurally and functionally modulated through a proteinaceous tether formed at speciﬁc subdomains of the ER
membrane, designated mitochondria-associated membranes or MAMs. The tethering function of the MAMs
allows the regulation of lipid synthesis and rapid transmission of calcium (Ca2+) signals between the ER and
mitochondria, which is crucial to shape intracellular Ca2+ signaling and regulate mitochondrial bioenergetics.
Research on the molecular characterization and function of MAMs has boomed in the last few years and the
list of signaling and structural proteins dynamically associated with the ER–mitochondria contact sites in physi-
ological and pathological conditions, is rapidly increasing along with the realization of an unprecedented com-
plexity underlying the functional role of MAMs. Besides their established role as a signaling hub for Ca2+ and
lipid transfer between ER and mitochondria, MAMs have been recently shown to regulate mitochondrial shape
and motility, energy metabolism and redox status and to be central to the modulation of various key processes
like ER stress, autophagy and inﬂammasome signaling. In this review we will discuss some emerging cell-
autonomous and cell non-autonomous roles of the MAMs in mammalian cells and their relevance for important
human diseases. This article is part of a Special Issue entitled: Calcium signaling in health and disease. Guest
Editors: Geert Bultynck, Jacques Haiech, Claus W. Heizmann, Joachim Krebs, and Marc Moreau.
© 2014 Elsevier B.V. All rights reserved.1. Introduction; a bird's eye view of the discovery andmain function
of the MAMs
The presence of a physical connection between the endoplasmic
reticulum (ER) and mitochondria was hinted for many decades and
indicated by pioneering electron microscopic observations by John
Ruby and co-workers, who saw a possible interplay between theACS, apoptosis-associated speck-like p
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However, mitochondria associated membranes (MAMs) were not dis-
covered as a biochemical entity until 1990, when Jean Vance isolated a
membrane structure through cell fractionation which she deﬁned as
the contact site between the ER and the mitochondria [2]. Thus, com-
pared with the ER, ﬁrst observed in 1945 [3], and the mitochondria, al-
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scribe the MAMs is that they represent ER membranes closely apposed
to mitochondria, which can be puriﬁed as distinct structures. A break-
through in the functional characterization of the MAMs only came up
to speed at the turn of the millennium, mainly through the work of
Rizzuto et al. [4]. They showed that the mitochondria are exposed to
higher Ca2+ concentrations than the cytosol after Ca2+ release from
the ER, suggesting the existence of microdomains of high Ca2+ concen-
trations and transfer between the ER and mitochondria that required a
physical, proteinaceous linkage between these two organelles. At this
time Vance's lab followed up its initial discovery by exploring the func-
tion of the MAMs in lipid homeostasis in rat liver cells [5]. Similar ﬁnd-
ings highlighting the key role MAMs play in lipid synthesis were also
soon reported in yeast cells [6], indicating the evolutionary conserved
functions of these ER–mitochondria contact sites. In the last decade
through the continuous advances in live-cell imaging techniques
allowing 3D reconstitutions of ER and mitochondria networks and so-
phisticated electron tomography studies, the total surface area of mito-
chondria juxtaposed to the ER has been estimated at around 5–20% [4].
It soon also became clear that the MAMs provide more than just a pro-
teinaceous link between these two organelles; they rather enable func-
tional transit of metabolites and signaling molecules between the ER
andmitochondriawith relevant implications in cell fate decisions. Now-
adays, even this statement seems to be underestimating the true role of
the MAMs and an increasing number of studies are emerging implicat-
ing this small piece of the cellular puzzle in a huge cascade of important
homeostatic functions within the cell and beyond. Recent excellent re-
views have discussed in great detail the impact of ER–mitochondriaTable 1
Functional role of theMAMs: summary of themost important signaling and functional roles of
references.
Function and signaling role
of the MAM
MAM resident
protein
Speciﬁc function(s) of MAM resident prot
Mitochondrial morphology DRP1 Amember of the dynamin family of protei
Miro1–2 Mitochondrial GTPase located at OMM co
trafﬁcking.
MFN2 Mitochondrial outer membrane GTPase an
Apoptosis signaling PML A tumor suppressor that by localizing at M
S1T Truncated form of the SERCA pump that l
PTEN Tumor suppressor that increases Ca2+ sig
Autophagy signaling ATG14L Early autophagy marker and an essential
autophagosome formation under starvatio
ATG5 Important protein in the formation of aut
Ca2+ transport VDAC1 Ca2+ uptake channel in the outer mitocho
IP3R Main Ca2+ efﬂux channel of the ER, linked
Grp75 Chaperone that forms a physical link betw
Cnx Ca2+ binding protein and chaperone of th
mTorc2 Mammalian target of rapamycin complex
Ca2+ increases by localizing at the MAMs
Sigma R1 receptor Chaperone that interacts with BiP and is i
Inﬂammation signaling NLRP3 Member of the NOD like receptor (NLR) f
is located at the MAMs
ASC Adaptor that binds NLRP3 to initiate inﬂam
Antiviral response MAVS Mitochondria-localized adaptor protein se
RIG-I Member of the RLRs family of cytosolic re
infection and binds to MAVS
ER–mitochondria tethering MFN2 OMM GTPase that can form homodimers
TpM A keratin binding protein that plays a role
PERK ER stress sensor and Ser/Thr kinase that p
response signaling
ER stress signaling CNX Ca2+ binding protein and chaperone of th
PACS-2 Cytosolic sorting protein involved in ER lo
PERK ER stress sensor and Ser/Thr kinase that p
Sigma R1 receptor Chaperone that interacts with BiP and is i
Ero1α An oxidoreductase acting as a major regu
conditions of ER stress
MFN2 Outer mitochondrial membrane GTPase th
BiP Interacts at the MAM with S1R and is an i
Other processes at theMAM γ-Secretase Multisubunit aspartyl protease member o
amyloid precursor protein, and found in l
PS1–2 Catalytic components of the γ-secretase ccontact sites for Ca2+ transfer and mitochondrial metabolism [7,8]
and thus this will not be addressed here. Rather in this review, after in-
troducing brieﬂy the main MAMmolecular components and their role
in modulating the ER–mitochondria interface, we will focus on some
emerging roleswhich have been ascribed to theMAMs and their impact
on the broader context of cellular function in physiology and in some
relevant pathological conditions.
2. MAMs; a dynamic collection of proteins recruited at the
ER–mitochondria interface
Just like the organelles they physically link, theMAMs should not be
seen as a static bridge linking ER andmitochondria. On the contrary, the
MAMs seem to be a highly ﬂexible and mercurial collection of proteins
that is able to recruit a variety of signaling components according to
the cell's need. In spite of the increasingly large number of proteins rec-
ognized to participate in this complex (see also Table 1), a core subset of
ER and mitochondria associated proteins has been identiﬁed that seem
to form thebasic components of theMAMs. These proteins include Ca2+
ion channels located at the ER or at the outermitochondrialmembranes
(OMM), like the inositol 1,4,5 triphosphate receptor (IP3R) [9] and volt-
age dependent anion channel 1 (VDAC1) [10], enzymes of the lipid bio-
synthetic pathways and lipid transfer proteins [11], various chaperones,
like the glucose-regulated protein 75 (Grp75) [10], the ER chaperone
calnexin (CNX) [12] and the sigma R1 receptor (S1R) [13,14], enzymes
involved in ER redox regulation, like the ER oxidoreductase 1 alpha
(Ero1α) [12,15–17], protein kinases, like the ER stress sensor double
stranded RNA-activated protein kinase (PKR)-like ER kinase (PERK)important MAM resident proteins mentioned in this review alongwith the corresponding
eins References
ns of large GTPases involved inmitochondrial ﬁssion initiated at theMAMs [29]
nnecting mitochondria to the cytoskeleton, and involved in mitochondrial [22]
d MAM component, which plays a major role in mitochondrial fusion [30]
AMs regulates IP3R Ca2+ signaling and mitochondrial Ca2+ overload [31]
eads to pro-apoptotic calcium overload in the mitochondria [32]
naling from the ER to the mitochondria through the IP3R [33]
pro-autophagic protein that relocalizes to the MAMs to induce
n
[34]
ophagosomes which associates with the MAMs [34]
ndrial membrane [10]
with VDAC1 through Grp75 [35]
een IP3R and VDAC1 [10]
e ER [36]
2 that is able to increase mitochondrial metabolism through regulated [37]
nvolved in IP3R mediated Ca2+ release regulation at the MAMs [13]
amily forming the multimolecular NLRP3-inﬂammasome whose assembly [38]
masome signaling [38]
rving as an important platform in cellular antiviral response [39]
ceptors involved in dsRNA sensing, it relocalizes to MAMs after viral [40]
and is a crucial mediator in ER–mitochondria tethering [24]
in ER–mitochondria tethering and Ca2+ signaling [41]
lays a role in ER–mitochondria tethering and unfolded protein [18]
e ER [12]
calization of transmembrane proteins and ER vesicle sorting [19]
lays a role in the unfolded protein response and interacts with MFN2 [42]
nvolved in IP3R mediated Ca2+ release [13]
lator of redox homeostasis in the ER, which associates with MAMs under [43]
at modulates PERK-mediated UPR signaling [44]
mportant ER chaperone and Ca2+ buffer [13]
f the intramembrane-cleaving protease family, which cleaves the
ipid rafts enriched at the MAMs
[45]
omplex, regulating ER–mitochondria apposition [45]
2255A.R. van Vliet et al. / Biochimica et Biophysica Acta 1843 (2014) 2253–2262[18] and proteins involved in the regulation of ER-vesicular sorting, like
phosphofurin acidic cluster sorting protein 2 (PACS-2) [19,20]. Proteins
involved in mitochondrial motility, like the mitochondrial Rho-
GTPase (Miro1, 2; also known as mitochondrial rho GTPase RHOT1, 2)
[21–23] and proteins regulatingmitochondrial shape and fusion/ﬁssion,
like the dynamin-related guanosine triphosphatase (GTPase) and
mitofusin 2 (MFN2) have also been found in the MAMs [24]. MFN2 is
one of the best studied MAM-resident proteins, whose effects on
MAMs structure and function have been reported in different studiesFig. 1. Schematic representation of the complex ER–mitochondria connections and the pathway
with mitochondria. Here we show a model of mitochondrial ﬁssion where an ER tubule wraps
ring around the outer mitochondrial membrane (OMM) and constrict it at that site. Mitochon
protein 1 (Fis1) are also involved in mitochondrial ﬁssion but their roles and links with DRP1 a
play a role inmaintaining general mitochondrial morphology, like mitochondrial Rho (Miro), v
proteins, like PERK (double strandedRNA-activated protein kinase (PKR)-like ER kinase), calnex
75 (Grp75), ER oxidoreductase 1α (Ero1α), STIM (stromal interactionmolecule). Also displayed
(Ca2+) and reactive oxygen species (ROS). (B) Detailed overview of the mitochondria-associat
roles of the MAMs are shown. Displayed is the antiviral response in the MAMs (in the form of M
and interferon (IFN)), calcium handling (in the form of inositol 1,4,5-trisphosphate receptor (IP
Ca2+ ATPase, (S1T), PML (promyelocytic leukemia), phosphatase and tensin homolog delete
tethering (in the form ofmitofusin 2 (MFN2), trichoplein/mitostatin (TpM)), inﬂammasome signa
tein containing a CARD, (ACS)) and autophagy regulation (in the form of ATG14L and ATG5). Var(Table 1). This GTPase, which is located on both the OMM and the ER
membranes, is able to establish homotypic as well as heterotypic (with
the OMM-associated MFN1) ER–mitochondria interactions, which
provide stability to the interface between these organelles. In line with
this, MFN2 ablation in murine ﬁbroblasts led to the disruption of the
ER–mitochondria contact sites, increasing the distance between these or-
ganelles, and caused a change in both the ER andmitochondrialmorphol-
ogy [24]. Importantly, loss of MFN2 also caused a defectivemitochondrial
Ca2+ uptake [24], demonstrating howdisruption of the ER–mitochondrias they regulate. (A) Global view of various endoplasmic reticulum (ER) tubules interacting
around a mitochondria and recruits dynamin-1-like protein (DRP1) locally to form a tight
drial ﬁssion will soon follow. Mitochondrial ﬁssion factor (Mff) and mitochondrial ﬁssion
re still not entirely clear. Besides the ﬁssion machinery, other proteins shown in this ﬁgure
oltage dependent anion channel 2 (VDAC2), mitochondrial uniporter (MCU), and some ER
in (CNX), phosphofurin acidic cluster sorting protein 2 (PACS-2), glucose regulatedprotein
is a graphical representation of themitochondrial electron transport chain (ETC), calcium
ed membranes (MAMs) themselves, where the various important functions and signaling
AVS (mitochondrial antiviral-signaling protein), retinoic-acid-inducible protein 1 (RIG-I)
3R), voltage-dependent anion channel 1 (VDAC1), truncated sarco/endoplasmic reticulum
d on chromosome 10 (PTEN)), ER stress related proteins (like PERK), ER–mitochondria
ling (in the form of NOD-like receptor family 3 (NLRP3), apoptosis-associated speck-like pro-
ious ER chaperones (CNX, Grp75) that assist the various functions are also shown.
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chondria and overall calcium homeostasis, with vital consequences on
cellular fate (Table 1 below has a summary of the most important MAM
components that are listed in this review. Also, Fig. 1 has a graphical
representation of many of these proteins and their interactions).
In spite of this handful of proteins repeatedly found located at
theMAMsof various cell types, it is still unclear if all connections between
themitochondria andER consistently have the sameprotein composition.
A recent shotgun proteomics study has identiﬁed more than 1212 pro-
teins associated to the MAM fraction isolated from mouse brain and
liver tissues [25]. When all these proteins were categorized according to
their functional involvement in biological processes, someof themost sig-
niﬁcant were processes affecting key mitochondrial functions, including
oxidative phosphorylation, lipidmetabolism and Ca2+ trafﬁcking, further
highlighting the importance of the MAMs in the metabolic and homeo-
static control of the cells [25]. In yeast, a recently characterized ER–
mitochondria tethering complex, named the ER–mitochondria encounter
structure (ERMES), was shown to be composed of a ﬁxed set of proteins,
i.e.,Mmm1/Mdm10/Mdm12/Mdm34. Amutation in one ormore of these
proteins weakened the ER–mitochondria connection and caused disrup-
tion in phospholipid synthesis [26]. This discovery has given the research
of these contact sites a whole new dimension, for example leading to the
characterization of Gem1, a Miro orthologue in yeast, which is the only
protein of the ERMES complex to date that can be unambiguously identi-
ﬁed in metazoan cells [23].
An outstanding and still open question is which intracellular
signal(s) triggers the initial induction of the MAMs at speciﬁc ER mem-
brane subdomains and dynamically regulates/terminates them. An
early study in yeast indicated that ER shaping proteins like Sey1P
(atlastins in mammals) assist in the formation of ER tubules and are
necessary for proper connection and lipid transfer between the ER and
mitochondria [27], suggesting that proper control of ER tubulation has
a major impact on the functional cross-talk with the mitochondria. Fur-
thermore, the potential relevance of a MAM-targeting motif was sug-
gested by the ﬁnding that a mitochondrial targeting sequence found
in the cytosolic domain of the transmembrane acyl-CoA:diacylglycerol
acyltransferase 2 (DGAT2), was required for its targeting to the ER–
mitochondria contact site [28]. However, the generality of this ﬁnding
could not be expanded to otherMAMproteins. Recently, palmitoylation
of cysteine residues in membrane-proximal and cytosolically exposed
domains has been shown to serve as a novel MAM sorting signal for
ER membrane proteins. In a recent study, the palmitoylation status of
the transmembrane domain of the thioredoxin family protein TMX
(members of the protein disulﬁde isomerase, PDI family) and CNX, was
shown to be required for their enrichment at the MAMs, since the muta-
tion of key palmitoylation sites abrogated their MAM localization [12].
Thus, not only structural changes driven by ER shaping proteins, but
also lipid molecular tags functioning as targeting sequences, appear to
regulate the dynamic assembly and possibly disassembly of the MAMs.
However, since palmitoylation served as a targeting mechanism for the
ER membrane proteins, but not of the peripheral proteins, like Grp75
[12], future research is needed to disclosewhether other, yet to be charac-
terized mechanisms contribute to the overall and dynamic make up of
MAM-associated proteins. Also the identity of the protein acyltransferases
(PATs) and a better understanding of the role of lipid raft-like domains as
assembly sites of MAMs at the ER membranes will be required.
3. ER–mitochondria contact sites: a delicate balance between life
and death
Besides their essential role in cellular metabolism and survival, it is
well established that the mitochondria play a key role in the initiation
and ampliﬁcation of cell death [46]. Given that excessive mitochondrial
Ca2+ uptake can favormitochondrial dysfunction and trigger apoptosis,
the involvement of MAMs in cell death modulation also comes as no
surprise. It has longbeen known that highermatrix Ca2+ levels sensitizemitochondria to undergo mitochondrial outer membrane perme-
abilization (MOMP), a process preceding apoptosis [47]. Increased uptake
of Ca2+ bymitochondria may result in changes in the permeability of the
inner membrane of the mitochondria (IMM) caused by prolonged open-
ing of the so-called permeability transition pore (PTP). PTP opening in
turn induces mitochondrial swelling and OMM rupture, with the conse-
quent release of caspase-activating factors and apoptosis induction [46].
Moreover, upon MOMP, cytosolic cytochrome C release can amplify cas-
pase activation by binding to the IP3R and exacerbating its Ca2+ leak
properties. This is a feed-forward loop, since a small amount of cyto-
chrome C released in the early phases of apoptosis will result in higher
Ca2+ transfer from the ER to the mitochondria, amplifying the apoptotic
signal [48].
Recently, another study has described an inter-organellar ampliﬁca-
tion signal involving ER–mitochondria contact sites. The studyof Iwasawa
et al. [49] delineated the existence of a reciprocal transfer of apoptosis sig-
nals, from the mitochondria to the ER, and back to the mitochondria,
through a complex formed at a speciﬁc ER–mitochondrial subdomain,
dubbed theARCosome. This signal entails that in response to an apoptotic
insult, a Bap31–Fis1 platform spanning the ER–mitochondria interface
would recruit caspase-8, thus enabling the cleavage of Bap31 into its
pro-death fragment p20Bap31, which favors the emptying of ER Ca2+
stores. Upon Ca2+ uptake, the juxtaposed mitochondria would then un-
dergo PTP opening and release apoptogenic factors, thereby launching
apoptosis. Interestingly, the disruption of MAMs by PACS-2 knockdown
has been shown to lead to Bap31 cleavage into p20Bap31 in the absence
of cell death [20]. This suggests that a tight association between ER
and mitochondria is required for this mechanism of Bap31-mediated
apoptosis. More and more studies implicate MAMs and a heightened
Ca2+ transfer in the modulation of Ca2+ ﬂuxes into the mitochondria
and in sensitization to apoptosis. This has also been reported for the
tumor suppressor protein phosphatase and tensin homolog deleted on
chromosome 10 (PTEN), which was recently identiﬁed to be located at
the MAM/ER compartment. PTEN, the lipid phosphatase downregulating
Akt signaling, has been found recently to play a role in increasing Ca2+
signaling to the mitochondria in situations of heightened ER stress and
pre-apoptotic signaling. This PTEN-mediated mechanism entails the
interaction with the IP3R/Akt complex resulting in a reduction of their
phosphorylation and an increase in Ca2+ release. Silencing of PTEN
caused the cell to be less sensitive to Ca2+mediated apoptotic stimulation
[50]. Notably, as it will be discussed later, PTEN is not the only tumor sup-
pressor protein found to exert a control of pro-apoptotic Ca2+ ﬂuxes in
stressed cells, thus highlighting the crucial relevance of a proper MAM
composition and functionality in the modulation of cell death.
As the previous paragraphs highlight, the state and efﬁciency of the
connection between the ER and mitochondria are prime determinants
of the regulation of Ca2+ levels in the mitochondria and thereby of ap-
optosis sensitivity. In light of this, it should be acknowledged that not
only the components of the MAMs are key factors in this crosstalk, but
also the distance of the ER–-mitochondria juxtaposition is important
[51]. Elegant work done in the laboratory of Hajnoczky, by using elec-
tron tomography and expression of synthetic linkers, addressed the
issue of the relevance of a proper ER–mitochondrial distance. These au-
thors found that the ER and mitochondria are juxtaposed through
trypsin-sensitive domains (thus proteinaceous in nature),which are ap-
proximately 10 nm across at the smooth ER and 25 nm at the rough ER
[52]. These close distances enable ER proteins to come in direct contact
with proteins and lipids at the OMM [7]. Tightening of these physical
links, either artiﬁcially through synthetic linkers, or by stimulating ER
Ca2+ release and transfer/uptake bymitochondria, led tomitochondrial
Ca2+ overload and MOMP, preceding apoptotic cell death. In contrast,
looseningwithout disrupting these ER–mitochondria contact sites stim-
ulated mitochondrial respiration and ATP production [52].
These studies together suggest that a tight ER–mitochondria juxta-
position is integral to the mechanisms controlling cellular fate and to
amplify (lethal) inter-organellar Ca2+ signals.
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The shape of the mitochondrial network is important to the general
function and health of the cell as well as for the spatiotemporal
coordination of signaling pathways. The interaction between ER and
mitochondria is emerging as a critical factor in the regulation of the dy-
namic changes in motility and shape of these organelles. The two main
ER structures are sheets and tubules. It has been speculated that the
sheet-like ER structure reﬂects active protein folding sites, since this
ER morphology is very suited for the binding of polysomes. Indeed,
ribosomes preferably localize to the sheet-like regions of the ER [53].
Tubular ER structures on the other hand are thought to be locations
where Ca2+ signaling and lipid synthesis take place [53,54]. Further-
more, the tubular structure of the ER is more suited to accommodate
budding vesicles and initiate contact with other organelles like the
mitochondria [53,54].
Like the ER, the mitochondria are also highly dynamic organelles
which, depending on the tissue, are often arranged in long tubular net-
works, sharing an interconnected reticulum that constantly branches,
fuses and fragments according to the impulse of metabolic stimuli, gen-
eral calcium buffering needs or in response to different cellular stresses.
Typically, under conditions ofmitochondrial Ca2+ overload or excessive
production of reactive oxygen species (ROS) themitochondrial network
undergoes either local or global fragmentation, and depending on the
type of stimulus, this morphological change can be transient or more
persistent [55,56]. Additionally,mitochondria need to be able tomigrate
acutely to areas where their metabolic activity or calcium buffering
capacity is required [56].
Accumulating data highlight an important role for the MAMs in the
coordination of ER andmitochondrial shape and dynamics. Indeed, sev-
eral proteins involved in mitochondrial movement along microtubules,
like dynein and kinesin, are tightly regulated by local Ca2+ concentra-
tion rises, a process regulated at the MAMs. It is known that mitochon-
drial motility is inhibited by a rise in the cytosolic Ca2+ concentration
[57,58]. The reduced motility of mitochondria causes an increase in
their association to the MAMs, subdomains of high Ca2+ release, there-
by enhancing their Ca2+ uptake and buffering capacity [57,59]. One of
the master regulators of mitochondrial motility based on local Ca2+
levels is the Miro family of proteins (Miro1 and 2). Both these proteins
are located at the OMM through a short C-terminal anchor domain.
Miro1 and 2 have two EF-hand Ca2+ binding domains through which
they are able to sense high levels of calcium. These proteins have an
important role in tethering the mitochondria to the cytoskeleton by
binding kinesin, thus enabling mitochondrial movement [22,60]. In
regions of high Ca2+, sensed by the EF hand domains of Miro1/2, the
connectionwith kinesin is lost and themitochondrion becomes station-
ary, enabling it to efﬁciently buffer (too) high cytosolic Ca2+ levels, or as
a means to stimulate oxidative phosphorylation [22,61]. As mentioned
previously, the yeast Miro orthologue Gem1 has been shown to have
an inﬂuence on the size and number of ERMES foci in the cell and to
affect phospholipid homeostasis. Whether, besides this important
function in the regulation of ER–mitochondria contact in yeast, Gem1
directly regulates the assembly of the ERMES complex as suggested in
another study, still remains a controversial issue [23,62,63].
Beyond the regulation of mitochondrial motility, MAMs participate
in the regulation of mitochondrial morphology, which is maintained
by a delicate balance between ﬁssion and fusion of mitochondria,
inﬂuencing the size, length and shape of the mitochondrial network
[56]. Mitochondrial fusion and ﬁssion are physiological processes occur-
ring in healthy cells and are highly linked to the energetic state of the
cell [56]. However, mitochondrial fragmentation is a process often stim-
ulated in response to cellular stress, where certain treatments or stress
signals (like those leading to increased production of reactive oxygen
species or ROS) that compromise mitochondrial membrane potential
and impair mitochondrial functions, are a trigger for fragmentation. In
order to prevent stress-induced damage spreading throughout theentire network, part of the damaged tubular mitochondria is ﬁssioned
and isolated, ready to be processed by the cell's autophagy machinery
(see below) [64,65]. The exact molecular mechanism by which mito-
chondrial ﬁssion occurs is not entirely known. A major player is the
highly conserved dynamin-related protein 1 (DRP1). DRP1 (or Dnm1
in yeast) contains three functional domains, a GTPase domain, a smaller
middle domain containing a pleckstrin homology domain with un-
known function and a C-terminal assembly or GTPase effector domain
(GED) [66]. DRP1 works by forming a helical oligomer in a GTP-
dependent manner through intra- and intermolecular interactions of
its three domains, enabling DRP1 oligomers to wrap around
a mitochondrion locally. This assembly of the DRP1 oligomer is
believed to provide the mechanochemical force that is able to induce
the ﬁssion of the outer and inner mitochondrial membrane [67]. DRP1
activity is further regulated through Ca2+ mediated phosphorylation/
dephosphorylation events by an OMM-associated kinase (PKA/AKAP1)
and phosphatase (PP2A/Bβ2). In neurons, the phosphorylation of
DRP1 at Ser656 caused the mitochondria to increase in length, while
its dephosphorylation induced mitochondrial fragmentation and depo-
larization [68]. Additional proteins, like mitochondrial ﬁssion factor
(Mff) and mitochondrial ﬁssion protein 1 (Fis1), both located on the
OMM are required for the proper ﬁssion of mitochondria but it is un-
clear if these proteins inﬂuence the location of ﬁssion, although both
Mff and Fis1 modulate the number and size of DRP1 punctae at the
OMM [69]. Recently however, an elegant study has linked tubular ER
formation with mitochondrial ﬁssion mechanics [29,70]. Here, the ER
is required to mediate mitochondrial ﬁssion at well-deﬁned points,
where ER tubules are seen to physically wrap themselves around a
part of themitochondrial network and induce local fragmentation. Fur-
thermore, it was shown that at these sites of close ER–mitochondria
contact, DRP1 was recruited; strongly indicating that mitochondrial ﬁs-
sion is induced at the MAMs (see Fig. 1 for a graphical representation).
The signals that trigger the required changes in ER morphology and
the local recruitment of the ﬁssion machinery at a speciﬁc site are still
unresolved. Given that mitochondrial fragmentation is often induced
after an insult that damages the mitochondrial network, mitochondrial
stress signals could be a triggering factor for local and heightenedMAM
formation. The fact that aftermitochondrial stress (oxidized) cardiolipin
(i.e., a phospholipid located nearly exclusively in the IMM)may become
exposed towards the cytoplasm, could implicate (oxidized) cardiolipin
as a trigger for the tightening of the ER–mitochondria contacts [71,72].
The observation that preventing the formation of phospholipid
hydroperoxides, thus protecting cardiolipin from oxidation, following
ROS-mediated ER damage and Ca2+ depletion by targeting glutathione
peroxidase 4 at themitochondria reducedmitochondrial fragmentation
and mitophagy [73], supports the hypothesis that redox mechanisms
involving the generation of phospholipid-peroxides may modulate the
recruitment of the ﬁssion/mitophagy machinery at the MAMs. This is
an intriguing hypothesis that needs future exploration.
5. MAMs and ER stress
The ER is a multifunctional organelle with various biosynthetic and
signaling functions. It is the primary site for the synthesis, folding and
posttranslational modiﬁcation of proteins destined for the cell mem-
branes or the extracellular space. Moreover, the ER constitutes the
major intracellular Ca2+ store and it plays a fundamental role in the
synthesis of steroids, cholesterol and various lipid constituents of cellu-
lar membrane structures [74,75]. Proper protein folding is not only a
crucial process to maintain homeostasis, it is also highly complex, re-
quiring the assistance of many folding enzymes and a specialized oxi-
dized environment [76]. The ER has thus evolved over time to provide
an ideal location for proteins to fold properly, being rich in Ca2+ and a
variety of chaperones. ER resident chaperones include the glucose regu-
lated protein 78 (Grp78, also known as BiP), the lectins calreticulin
(CRT) and CNX, enzymes dedicated to post-translation modiﬁcations
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zymes regulating the ER redox environment like Ero1α [15–17,75,77].
Protein folding is an energetically demanding process where ATP is re-
quired for chaperone function as well as for maintaining ER redox and
Ca2+ homeostasis. However, this process is not devoid of faults and re-
lies on a delicate balance between the capacity of the foldingmachinery
and folding load in the ER lumen. For example, when Ca2+ levels in the
ER drop in response to various insults and subsequently fail to recover,
the capacity of the ER machinery to properly fold proteins becomes in-
adequate. This state of the ER, where unfolded proteins accumulate in
the ER lumen, is called “ER stress”.
5.1. ER stress signaling and modulation at the MAMs
Specialized proteins in the ER membrane can speciﬁcally detect
this accumulation of unfolded proteins and engage a complex signal
transduction mechanism, a response termed “the unfolded protein re-
sponse” [78,79]. The three proteins able to sense ER stress are PERK,
IRE1 (inositol-requiring protein 1) and ATF6 (activating transcription fac-
tor 6) [42,80,81]. Upon ER stress these proteins will activate different sig-
naling pathways in order to try and solve the ER stress by expanding the
ER, upregulating chaperones and by causing a (temporary) translation
stop. This initial, adaptive phase of ER stress has been shown to be accom-
panied by changes in the general ER morphology and the strengthening
of the contact sites between the ER and mitochondria. Since the folding
of newly synthesized proteins is one of the most energy-demanding ac-
tivities in the cell, this makes sense. In line with this, after ER stress in-
duced by tunicamycin, a signiﬁcant proportion of mitochondria have
been found to relocate towards the perinuclear ER. These mitochondria
display an increase in their transmembrane potential, a higher Ca2+ up-
take, higher ATP production, a stronger reductive power and increased
oxygen consumption [82]. Thus, tightening the ER–mitochondria contact
sites could have the general purpose of favoring a temporal increase in
the intracellular ATP pool, which is required to support the pro-survival
ER stress transcriptional machinery leading to increased expression of
ER chaperones during the early adaptive phases of ER stress.
However, when ER stress is too severe and cannot be solved by the
UPR, the signaling pathways initiated by the three ER stress sensors
will turn on a lethal signal, eventually causing cell death, usually in
the form of apoptosis [78,79,83]. Several studies have corroborated a di-
rect link between changes in MAM components, deregulated Ca2+
transfer and apoptotic sensitivity during ER stress. For example, in a
mouse model of the human lysosomal storage disease GM1-
gangliosidosis, GM1-ganglioside was shown to accumulate in MAMs,
induce ER stress through stimulation of IP3R-mediated ER Ca2+ deple-
tion, mitochondrial Ca2+ overload and MOMP [84]; suggesting a link
between changes in the lipid composition and/or the lipid-raft like
structures of theMAMs and ER stress-mediated apoptosis. Furthermore
a study showed that S1T, a truncated variant of sarco/endoplasmic retic-
ulum Ca2+ ATPase (SERCA1) which is induced during ER stress, local-
ized to the MAMs and caused mitochondrial Ca2+ overload, increased
number of contact sites and inhibitedmitochondrialmovements and ul-
timately triggered apoptosis [32]. Interestingly, S1T upregulation during
ER stress was shown to be dependent on the PERK-ATF4 axis of theUPR,
suggesting that the activation of the PERK pathway following ER stress,
may indirectly reinforce the ER–mitochondria contact sites through
ATF4-mediated transcription of S1T [32].
However, PERK can facilitate exchange of signals through the ER–
mitochondria contact sites, by mechanisms that are also independent
of the UPR [18]. In line with this, we recently obtained evidence for a
direct role of PERK at the MAMs. Through subcellular fractionation
and functional studies, we found that PERK is an integral part of
the MAMs [18]. Genetic deletion of PERK in MEFs disrupted the ER–
mitochondria contact sites and conferred protection against apoptosis
in response to agents that simultaneously mobilize Ca2+ and induce
ER stress through ROS [18]. A recent paper from the group of Zorzanohas found that MFN2 can directly interact with PERK and this interac-
tion is required for the proper progression of ER stress mediated re-
sponses, including UPR signaling and apoptosis [44]. Interestingly,
these authors showed that the silencing of PERK could partially rescue
the fragmentation of themitochondrial network and the aberrantmito-
chondrial Ca2+ content caused by loss ofMFN2 inMEFs. Consistentwith
an important role of PERK in the maintenance of ER–mitochondria con-
tact sites, we also found that PERK ablation/inhibition impairs mito-
chondrial Ca2+ overload following discharge of ER Ca2+ by
thapsigargin and improves mitochondrial oxygen consumption under
these ER stress conditions (van Vliet et al., unpublished data). However,
more investigation is required to understand whether PERK-mediated
effects on mitochondrial bioenergetics rely on its ability as a MAM-
resident protein to favor a direct transfer of essential mediators/signal-
ing molecules between the ER and mitochondria, independently of its
canonical role in UPR signaling, moreover whether other interactors of
PERK at the MAMs, besides MFN2, exist still needs to be studied.
Recent results obtained in our laboratory have indicated that the
MAMs may be involved in the transmission not only of Ca2+ signals,
but also of certain toxic lipid oxidation products such as lipid peroxides,
to the mitochondria [73]. Given that various components of the mito-
chondrial Ca2+ transport chain are modulated by a redox-mechanism
[85], it would be interesting to establish whether exchange of lipid
peroxides may provide a ﬁne-tuning mechanism to propagate ROS
signaling mechanisms controlling mitochondrial Ca2+ uptake and cell
death decision after ER stress.
5.2. ER stress-MAMs and autophagosome formation
Giving further credence to observations linking MAMs to ER stress
(and more general cellular stress), new reports have implicated the
ER–mitochondria contact sites in the formation of autophagosomes
[34], the structural hallmark of macroautophagy (hereafter called sim-
ply autophagy). Autophagy, the main lysosomal degradation pathway
for the removal and recycling of intracellular components, including
superﬂuous/damaged proteins and organelles [86], is stimulated by the
lack of nutrients and oxygen orwhen proteostasis or organellar function-
ality is compromised [87,88]. Consistently, conditions leading to ER stress
prime also the autophagicmachinery, which is stimulated to assist the re-
moval of unfolded proteins and relieve the burden on the ER [89] (for an
extensive review on molecular autophagy readers are referred to [87]).
Although it has been known for some times that themembrane of the
autophagosome originates largely from the ER membranes [90], the mo-
lecular link between autophagy and the ER–mitochondria subdomains
was only recently delineated. Intriguingly, a recent study by the group
of Yoshimori has shown that the pre-autophagosome marker ATG14L
(autophagy related 14L, an essential pro-autophagic protein), relocalizes
to theMAMsafter starvation [34]. In linewith this, the physical disruption
of theMAMsprevented bothATG14 recruitment and autophagosome for-
mation. Interestingly, ATG5, another essential autophagy gene, was also
found to localize to theMAMsuntil the process of autophagosome forma-
tion was complete [34]. The fact that autophagy is crucial to maintain a
proper and functional mitochondrial network [91,92] makes these
recent discoveries even more appealing. In fact, recruitment of the
autophagymachinery at theMAMs could couple the previously described
effect of the MAMs on mitochondrial ﬁssion mechanics to the regulation
of mitochondrial clearance or mitophagy [93]. Whether MAMsmodulate
other forms of autophagy, like chaperone-mediated autophagy or
microautophagy, remains to be established.
6. MAMs and the cellular immune response
6.1. MAMs in antiviral response
As we have outlined so far, the MAMs play a central role not only in
the communication between the ER and the mitochondria but also in
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many downstream mechanisms. Its role in the anti-viral response of
the cell also falls into this category. One of the most important signs of
infection for many viruses is the replication of double stranded RNA
(dsRNA). The ﬁrst line of defense a cell has to initiate an antiviral re-
sponse is the DExD/H box-containing retinoic acid inducible gene I
(RIG-I) [40,94]. RIG-I has a peculiar feature in that it contains two cas-
pase recruitment domains (CARD) at its N-terminus, which function
as a positive regulator of interferon (IFN). The main function of RIG-I
is its ability to recognize non-self-cytosolic RNA, whereupon it initiates
a signaling cascade leading to the upregulation of type 1 interferon and
other proinﬂammatory cytokines in order to induce an innate anti-viral
immune response [95]. Type I IFN (comprising the IFN-beta and the
IFN-alpha families) is important in this regard because it also has a pre-
paratory role in the subsequent adaptive immune response.When RIG-I
senses non-self RNA, it is recruited to its adaptor protein MAVS (mito-
chondrial antiviral-signaling protein, formerly known as VISA/CARDIF/
IPS-1). MAVS is a central hub for the cellular anti-viral response and
the signaling pathway initiated by RIG-I upon recognition of dsRNA is
relayed through MAVS. MAVS had already been shown to be localized
not only to mitochondria but also to peroxisomes [39,96]. Recently
however, it has been discovered that the MAMs also represent one of
themain sites whereMAVS is localized, marking ER–mitochondria con-
tact sites as a prime cytoplasmic location involved in the cellular anti-
viral response. During viral infection RIG-I is recruited at the MAMs in
order to bindMAVS, a process that is supported by the ER–mitochondria
tethering function of MFN2 [97]. Intriguingly, the hepatitis C virus
(HCV) NS3/4A protease, which cleaves MAVS in order to avoid the
induction of a strong anti-viral response, was shown to target this
MAM-associated complex, strongly supporting the view that the regula-
tion of innate immune signaling requires an integral MAVS complex at
the MAMs.6.2. MAMS and the inﬂammasome
A further process that could heavily involve the MAMs is the forma-
tion and regulation of the inﬂammasome, a multimolecular complex
that serves as a platform for the activation of a signaling pathway that
leads to the processing and release of the pro-inﬂammatory cytokines
IL-1β and IL-18 [98,99]. There is a whole family of inﬂammasomes,
each sensing slightly differing types of triggers and having different
roles. Among these are the NOD-like receptor family 3 (NLRP3), absent
in melanoma 2 (AIM2), NLR family CARD domain-containing protein 4
[98]. Of these different protein complexes, previously published data
have shown that NLRP3 localizes to the OMM and the ER [38]. The
exact mechanism by which the NLRP3 inﬂammasome is activated is
still not fully known. However, upon the activation of NLRP3 using
nigericin (an antibiotic) or monosodium urate (MSU), NLRP3 recruits
an adaptor protein called apoptosis-associated speck-like protein con-
taining a CARD (ASC) which then leads to the conversion of procaspase
1 to cleaved/active caspase 1. Caspase 1 is then able to process cytoplas-
mic targets, like pro-IL-1β. The group of Tschopp observed that upon
inﬂammasome activation by MSU or nigericin, NLRP3 and ASC proteins
co-localized to theMAM fraction [38]. Exactly how theMAM is involved
in inﬂammasome activation is not known as of yet. Interestingly, one of
the physiological triggers of NLRP3 activation is ROS, and given that the
mitochondria and the ER are the prime locations of intracellular ROS
formation, this could suggest that MAMs may become locally enriched
in ROS or ROS derived signaling molecules and recruit ROS-sensing
proteins. In line with this hypothesis, upon knockdown of VDAC1, and
thus the reduction of mitochondrial ROS production, caspase 1 activity
and IL-1β production were severely downregulated [38]. Thus, these
ﬁndings highlight the central role of the MAM in the coordination
of cell-non-autonomous functions like inﬂammation and antiviral
immunity.6.3. MAM deﬁciency and disease
With the ever increasing amount of information and characteriza-
tion of the MAMs, there are more and more indications that dysfunc-
tional MAMs could be an important precursor of disease [25]. Here we
brieﬂy discuss some human pathologies, which appear to be linked by
alterations in MAM function.
6.4. MAMs and neurodegenerative disease
Accumulating evidence implicates an altered MAM functionality in
the pathogenesis of Alzheimer disease (AD). Recent studies illustrate
that in samples from patients having familial (FDA) or sporadic (SDA)
forms of AD,MAM functionality, measured by the amount of cholesterol
and phosphatidylserine production, is increased [45]. Likewise an
increased expression of MAM-associated proteins is found in post-
mortem AD brain [100]. Interestingly, lipid raft domains of the MAMs
have been found to be a primary site for γ-secretase activity and amy-
loid precursor protein (APP) localization; presenilins 1 and 2 (PS1 and
PS2), two aspartyl protease components of the γ-secretase complex
which are dysregulated/mutated in AD were also found to localize
strongly to the MAMs [101]. Since the γ-secretase complex catalyzes
the cleaving of the beta-amyloid precursor protein (APP) and a faulty
cleavage and processing of this protein is thought to be one of the
main causes of AD [102], these ﬁndings further support the concept
that MAMs are crucial sites regulating this process. This hypothesis is
moreover in line with observations linking mitochondrial dysfunction,
Ca2+ signaling, altered lipid and glucose metabolism and inﬂammation
with the pathogenesis of AD [103–106]. Recent investigations by the
group of Eric Shon on the molecular/signaling mechanisms causing
MAM alterations in the context of AD, showed that silencing/deﬁciency
in either PS1 or 2 or both, enhanced the contact between the ER andmi-
tochondria along with an upregulation of MAM function, thus implicat-
ing PS1/2 as negative regulators of this connection. However, a previous
study from the lab of Pizzo reported that PS2 (but not PS1) enhances
Ca2+ shuttling between the ER and mitochondria by increasing the
number of ER–mitochondria contact sites. This effect was furthermore
reduced by PS2 down-regulation and enhanced by the expression of
FDA PS2 mutants [107]. While the reason for this discrepancy is still
not completely understood, and may involve different experimental
models or approaches used in these studies, it is clear that alterations
in lipid and Ca2+ signaling provoked by a disturbed ER–
mitochondria connection are an important factor in the pathogenesis
of AD. This is a link that needs to be further explored.
Another neurological disease where MAM dysfunction may have an
important role to play is Parkinson's disease (PD). Mutations in the
Parkin and PTEN induced putative kinase 1 (PINK1) genes lead to
familial PD,making them the focus ofmuch research into this pathology
[108,109]. Recently, it was shown that Parkin is able to interact with
MFN2 and together with PINK1 mediate the ubiquitination of this pro-
tein. Ubiquitination ofMFN2 promotes the local ﬁssion of themitochon-
drial network, leading to the interesting hypothesis that Parkin is
causing local mitochondrial ﬁssion in order to sequester the damaged
mitochondria for autophagic clearance [110]. In support of this hypoth-
esis, a new study has shown that the ER–mitochondria contact sites are
prime locations for Parkin-mediated mitophagy and local recruitment
of LC3 [111]. This is moreover also consistent with studies highlighting
the MAMs as subcellular locations where autophagy is induced.
6.5. MAMs in skeletal and cardiac muscle physiopathology
One of the tissues where the ER–mitochondria contact sites appear
to have a crucial role is the skeletal and cardiac muscles (where the ER
is called sarcoplasmic reticulum, or SR). In these tissues, a balanced
and ﬁne-tuned Ca2+ communication between the mitochondria and
SR is essential. Upon muscle contraction, ryanodine receptor (RyR)
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order to increase local ATP production, through the increased activity
of Ca2+-sensitive matrix dehydrogenases (CSMDHs). Besides its role
in Ca2+ transfer and mitochondrial energetics, the RyR has also been
shown to play a role in the establishment of SR–mitochondria coupling
in differentiating muscle cells (H9c2 myoblasts) [112]. Moreover, a
disturbed RyR-mediated Ca2+ signaling appears to underlie different
muscle-related pathologies. Mutations in RyR1 have been described
in patients with malignant hyperthermia and central core disease. In
these diseases the cytosolic and mitochondrial Ca2+ transients are
altered because of defective RyR-mediated Ca2+ signaling from the SR,
leading to aberrant and damagedmitochondria [113,114]. Mitochondri-
al Ca2+ overload and PTP opening play a role in the mdx mouse model
of Duchennemuscular dystrophy, caused by loss-of-functionmutations
in the cytoskeleton-to-extracellular matrix-anchoring protein dystro-
phin. In dystrophic skeletal muscle altered SR-mitochondrial Ca2+
transfer (in part due to RyR1 dysfunction) and elevated ROS levels pro-
duced by mitochondrial NADPH oxidase (NOX), amplify each other to
induce mitochondrial damage and thus possibly leading to the unusual
sensitivity to stress of these skeletal muscle cells [115].
6.6. MAMs and cancer
A role for MAMs in cancer disease has not been thoroughly investi-
gated yet. In spite of this there are a number of indications suggesting
that MAMsmay have a bright future in cancer research. A clear link be-
tween MAMs and cancer comes in the form of promyelocytic leukemia
(PML) and Akt, a proto-oncogene frequently found upregulated in
cancer. PML is a nuclear tumor suppressor that acts by suppressing
oncogenic pathways, like the PI3K/Akt pathway, and a regulator of
apoptosis. Not surprisingly, PML function is frequently lost or defective
in various human tumors [116]. It has now been shown that an extranu-
clear pool of PML localizes to the MAMs where it modulates, through
the interaction with protein phosphatase 2A, the Akt-dependent IP3R
phosphorylation [31]. As mentioned before, the phosphorylation state
of IP3R is an important characteristic in determining the amount of
Ca2+ efﬂux from the ER to the mitochondria [117]. The PML pool at
the MAMs thus is critical for apoptotic propagation of the Ca2+ signals
through the IP3R to the mitochondria, leading to mitochondrial Ca2+
overload and subsequent apoptosis under conditions of cellular stress
[118]. Likewise, as described before, PTEN can also inﬂuence Akt/IP3R
signaling by localizing at the MAMs, further indicating that the ER–
mitochondria contact sites are prime locations in the regulation of can-
cer cell fate. Intriguingly, a recent study has shown that the target of
rapamycin complex 2 (mTORC2), a crucial sensor of nutrient availability
and metabolism and upstream activator of Akt, can be recruited to the
MAMs in growth factor stimulated cells [119]. The association of
mTORC2 to MAMs promoted its interaction with the IP3R–Grp75–
VDAC1 complex, regulated ATP production and mitochondrial calcium
uptake, and was associated with increased Akt-mediated phosphoryla-
tion of IP3R, hexokinase 2 (HK2) and PACS-2, which was required for
the integrity of the MAMs. Moreover, the MAM-associated mTORC2-
mediated activation of Akt fostered HK2-mediated energy metabolism
and increased cell survival. In line with this, a whole-genome shRNA
screen revealed that mTORC2-addicted cancer cells are dependent on
both mitochondrial function and aerobic glycolysis [37]. Following up
in the same vein, TpM (trichoplein/mitostatin) a cytoskeleton-binding
protein that is downregulated in human breast, prostate and bladder
cancers [120,121], has been shown to play an important role in the
ER–mitochondria contact sites and in themodulation of Ca2+ signaling,
by interactingwithMFN2 [41]. Forced expression of TpM inducedmito-
chondrial ﬁssion and reduced the tethering with the ER and apoptosis
evoked speciﬁcally by Ca2+ releasing stress factors, while TpM
silencing had opposite effects [41]. Although the consequence on mito-
chondrial bioenergetics was not explored in the latter study, it is clear
that inﬂuencing the tethering and Ca2+ signaling between the ER andmitochondria by modulating the recruitment of various oncogenes
and tumor suppressor genes at the MAMs have crucial repercussions
on metabolism and apoptosis, two processes altered in cancer diseases.
6.7. MAMs in anticancer therapy
A major goal of virtually all anticancer therapies is to re-establish
cancer cell sensitivity to killing. Thus, are the integrity and the function
of theMAMs relevant for therapeutic intervention?While the answer to
this intriguing question has not yet been addressed systematically,
there may be a relevant connection between MAMs and immunogenic
cancer cell death (ICD). Studies in our and other laboratories have
shown that ER stress is an essential component of the danger signaling
underlying ICD, an apoptotic cell death modality that enables the dying
cancer cells to stimulate, rather than repress, a host anti-tumor immune
response to eliminate residual disease [122,123]. Recent studies [124,
125] uncovered that PERK governs the pre-apoptotic emission of crucial
immunological mediators — i.e. damage-associated molecular patterns
(DAMPs) - from the dying cancer cells, following anticancer modalities
strongly based on ROS-mediated ER stress. Whether the novel role of
PERK at the MAMs is important to deﬁne the immunogenicity of the
dying cancer cells for which ROS-based ER stress is vital, is an intriguing
possibility that deserves to be further investigated. Additionally, as
discussed above, MAMs have been found to be important for NLRP3
inﬂammasome signaling, which is stimulated upon the binding of
ATP, released by the dying cancer cells during ICD, to the purinergic
P2RX7 receptor (purinergic receptor P2X, ligand-gated ion channel,
7) on the surface of dendritic cells (DC) [125]. Thus, MAMs may not
only coordinate the emission of danger signals by the dying cancer
cells succumbing to ICD, but could also play a critical role in the activa-
tion of theDC inﬂammasome,which is thought to be a crucial step in the
propagation and stimulation of anti-tumor immunity [125]. Future
studies will be required to fully explore the biological signiﬁcance of
the MAMs during carcinogenesis and following anticancer treatments
based on major ER stress components, such as those stimulating ICD.
7. Concluding remarks
Accumulating evidence indicates that the MAMs are a subcellular,
versatile and important signaling site connecting two of the most criti-
cal organelles of the cell, the ER and mitochondria. Recent research
has highlighted and broadened the functional roles ofMAMs in a variety
of cellular processes from lipid synthesis/transport, Ca2+ signaling and
ER stress, to mitochondrial shape and autophagy/mitophagy and to
inﬂammation and cell immunity. While care should also be taken in
safeguarding against over-enthusiasm and proper validation has to be
taken to ensure speciﬁc isolation/identiﬁcation of MAM components
and associated signaling pathways, there are many outstanding ques-
tions that deserve future research. To mention a few: how can such a
small sub-cellular organelle have such a myriad of functions? Is it feasi-
ble to assume that different MAM connections will accommodate all
these different cellular purposes?What are theMAM-docking signal(s)
that enable the interaction of molecular complexes initiating down-
stream signaling pathways? Besides Ca2+, which other signaling medi-
ators or molecules are engaged in the modulation of ER–mitochondria
inter-organellar function? Is the role of MAMs in diseased conditions
explained mainly by their emerging role in mitochondrial Ca2+ and
energy homeostasis? There is no doubt that at the pace at which the
rapidly expanding ﬁeld of MAMs research is moving on, we will soon
have answers to these intriguing questions.
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